MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

02 Nov 2021 Evaluate
The sales for the September 2021 quarter moved down -30.62% to Rs. 101.74 millions as compared to Rs. 146.65 millions during the year ago period.Net profit was down at Rs. 2.76  millions against Rs. 21.54 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -87.19%.Operating profit for the quarter ended September 2021 decreased to 38.68 millions as compared to 59.87 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 101.74 146.65 -30.62 231.65 238.19 -2.75 517.75 553.52 -6.46
Other Income 0.24 0.00 0.00 2.44 0.00 0.00 0.79 0.53 49.06
PBIDT 38.68 59.87 -35.39 86.98 88.73 -1.97 177.43 125.24 41.67
Interest 10.64 10.30 3.30 19.24 17.34 10.96 35.29 30.98 13.91
PBDT 28.04 49.57 -43.43 67.74 71.39 -5.11 142.14 94.26 50.80
Depreciation 17.39 12.59 38.13 35.26 25.23 39.75 55.91 51.72 8.10
PBT 10.65 36.98 -71.20 32.48 46.16 -29.64 86.23 42.54 102.70
TAX 7.89 15.44 -48.90 17.40 14.84 17.25 29.37 -1.89 -1653.97
Deferred Tax 4.86 8.04 -39.55 9.32 5.61 66.13 15.79 -13.11 -220.44
PAT 2.76 21.54 -87.19 15.08 31.32 -51.85 56.86 44.43 27.98
Equity 142.04 128.87 10.22 142.05 128.88 10.22 134.19 128.88 4.12
PBIDTM(%) 38.02 40.83 -6.87 37.55 37.25 0.80 34.27 22.63 51.46
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..